U.S. Residential REITs Stock News

In August 2026, Corebridge Financial, Inc. declared a US$0.25 per-share common dividend, completed a US$5.96 billion share repurchase program after buying back an additional US$300 million in stock, and reported second-quarter 2026 results showing revenue of US$3,914 million and net income of US$2 million compared with a net loss a year earlier. Alongside the earnings improvement, Corebridge expanded its Power Series of Index Annuities with the Protected Growth Benefit and preset allocation...

Pulse Biosciences (PLSE) is back in focus after reporting a wider quarterly net loss and filing a US$75 million at the market equity offering, as its NANOPULSE-AF Study passes the enrollment midpoint. See our latest analysis for Pulse Biosciences. The recent NANOPULSE-AF Study milestone and the US$75 million at the market offering come after a powerful run in Pulse Biosciences' stock, with a 30 day share price return of 61.32% and year to date share price return of 216.73%. The 3 year total...

AnaptysBio (ANAB) has drawn investor attention after recent share price moves, with the stock last closing at US$56.61. The company focuses on immunology therapeutics for autoimmune and inflammatory diseases. See our latest analysis for AnaptysBio. Recent trading has been choppy. The stock has a 1-day share price return of 3.36% and 7-day share price return of 5.50%. However, it is down 14.73% over 30 days, while the year-to-date share price return is 25.94% and the 1-year total shareholder...

Amerant Bancorp (AMTB) recently appointed Yecimar Tirado Camacho as Executive Vice President and Chief Risk Officer. This leadership shift draws fresh attention to how the bank manages risk and how the stock is currently valued. See our latest analysis for Amerant Bancorp. Amerant Bancorp shares now trade at US$28.91, with the 30 day share price return of 13.37% and year to date share price return of 46.68% pointing to building momentum. The 1 year total shareholder return of 54.27% shows...

AeroVironment (AVAV) has attracted fresh investor attention after a reported US$400 million U.S. Army production contract for its Locust directed energy counter drone system, alongside meaningful boardroom changes. See our latest analysis for AeroVironment. AeroVironment’s shares recently moved sharply higher, with a 1-day share price return of 9.12% and 30-day share price return of 29.15%. However, the year-to-date share price return is down 27.11% and the 1-year total shareholder return is...

National HealthCare Corporation recently reported past second-quarter 2026 results showing revenue of US$408.03 million and net income of US$40.32 million, alongside a declared quarterly dividend of US$0.67 per share payable in October 2026. The sharp improvement in earnings per share from continuing operations compared with a year earlier highlights stronger profitability across both the quarterly and six-month reporting periods. Next, we’ll examine how this stronger earnings performance...

Somnigroup International has delivered a 56.6% gain over the past 5 years, yet its current checks point to a mixed valuation picture, with an intrinsic value estimate from a Discounted Cash Flow (DCF) model suggesting the stock may still trade below its underlying worth, while market multiples look closer to fair. Over the last 5 years Somnigroup International shares are up 56.6%, which indicates shareholders with a longer horizon have seen solid compounding despite more recent weakness. The...

United Community Banks stock has returned 35.0% over the past three years, while the current checks suggest a mixed picture on value and an intrinsic value estimate that sits materially above the recent market price. With the shares last closing at US$35.51, the Excess Returns model indicates the stock trades at a meaningful discount to its assessed intrinsic value, even as earnings-based multiples look broadly in line with peers. Over the past three years United Community Banks has...

Huntington Ingalls Industries (HII) has drawn fresh investor attention after signing long term, performance based production agreements with GrayMatter Robotics and Path Robotics to expand physical AI automation across U.S. Navy shipbuilding programs. See our latest analysis for Huntington Ingalls Industries. These automation agreements come after a busy few weeks for Huntington Ingalls Industries, with the stock at $324.48 and a 30 day share price return of 13.42% helping to offset a year to...

Sabine Royalty Trust recently reported past August 2026 production results showing oil volumes of 72,119 bbls versus 54,139 bbls in the prior month and gas volumes of 1,408,574 Mcf versus 1,074,976 Mcf, alongside a higher cash distribution of US$0.619430 per unit payable on August 31, 2026. This combination of stronger recent oil and gas output and a raised distribution highlights how current asset performance is supporting higher cash payouts. We’ll now examine how the increased cash...

AGNT, Inc ( NASDAQ:AGNT ) stock is about to trade ex-dividend in three days. The ex-dividend date is one business day...

Cheniere Energy Partners, L.P. recently reported past second‑quarter 2026 results, with revenue rising to US$2,583 million and net income to US$1,161 million, alongside higher earnings per unit, and also affirmed a total cash distribution of US$0.820 per common unit payable in August 2026. The sharp increase in quarterly net income compared with the prior year highlights a substantial improvement in profitability, reinforcing the importance of its liquefied natural gas export operations for...

Quanta Services recently completed a multi‑tranche fixed‑rate senior unsecured notes offering totaling US$2.00 billion, with maturities in 2029, 2033 and 2036, to fund general corporate purposes and repay borrowings under its commercial paper program and senior credit facility. This financing, following a quarter of higher sales and earnings and raised full‑year 2026 guidance, underscores the company’s access to capital and its balance sheet flexibility as it supports ongoing grid and...

Super Micro Computer (NasdaqGS:SMCI), AMD and Spectro Cloud announced AMD Instinct Coder, an enterprise AI inference solution for private AI deployments. The jointly developed offering combines validated hardware and software to replace piecemeal AI infrastructure projects with a single integrated stack. AMD Instinct Coder is designed for hybrid use across on premises and cloud environments, with policy driven model routing for different workloads. The launch positions Super Micro Computer...

Doximity earnings spark fresh focus on AI and valuation Doximity (DOCS) has jumped back onto investors' radar after its early August first quarter report, which combined revenue growth, a high adjusted EBITDA margin and a higher full year revenue outlook. The earnings release also highlighted rapid take up of Doximity's clinical AI tools, independent recognition of their safety profile and early monetization of new AI features, all against a backdrop of mixed analyst views on the stock. See...

Why MKS stock is back in focus after fresh earnings, guidance and a dividend update MKS (MKSI) is in the spotlight after releasing second quarter 2026 results, issuing third quarter guidance, and affirming a quarterly cash dividend that together give investors fresh data to assess the stock. See our latest analysis for MKS. Despite the strong earnings update, MKS has seen mixed momentum lately. The 1-day share price return of 4.70% contrasts with a 30-day share price return that is down...

Bending Spoons (BSP) stock is drawing fresh attention after the company opened its third European office in Madrid, expanding its physical presence and recruitment reach across key technology hubs. See our latest analysis for Bending Spoons. Alongside the Madrid opening and the recent €1,490 million financing package, Bending Spoons has seen the share price at $44.45 after a 35.07% 30 day share price return and a 9.75% year to date share price return, suggesting momentum has recently picked...

Service Properties Trust recently reported its second-quarter 2026 results, with revenue falling to US$420.97 million from US$503.44 million a year earlier and net loss widening to US$223.84 million from US$38.16 million. Although the six-month net loss increased to US$375.02 million, basic loss per share from continuing operations was largely unchanged at US$4.63 versus US$4.67 a year earlier, suggesting the larger loss is being spread across a bigger share base. We’ll now examine how this...

In early August 2026, Dynatrace reported first-quarter revenue of US$554.55 million, up from US$477.35 million a year earlier, while net income eased to US$36.65 million, and the company slightly trimmed full-year revenue guidance and confirmed second-quarter expectations. Alongside launching advanced Dynatrace Intelligence AI agents, completing a US$425.95 million share buyback, and announcing its long-serving CFO’s planned retirement, Dynatrace also added AI veteran Chandu Thota to its...

NCR Voyix Corporation recently reported its second-quarter 2026 results, posting revenue of US$523 million and net income of US$2 million, while maintaining full-year 2026 revenue guidance of US$2.19 billion to US$2.30 billion. The company also continued its long-running capital return program, completing repurchases of 24,282,592 shares for US$495.82 million since 2017, which reduces the share count and can meaningfully affect per-share metrics. Now we’ll explore how maintaining full-year...

In July 2026, QuantumScape reported Q2 results and updated the milestone structure of its PowerCo collaboration, which is intended to support the development and validation of battery cells over the following two years.

CACI International (CACI) is back in focus after reporting record fiscal 2026 revenue, EBITDA margin, and free cash flow, along with fiscal 2027 guidance that points to continued double-digit revenue growth and strong cash generation. See our latest analysis for CACI International. CACI International's recent earnings release and contract wins appear to have shifted sentiment, with a 7 day share price return of 25.7% and a 30 day share price return of 32.5% pointing to strong near term...

HealthEquity stock has delivered a 61.0% return over the past 5 years, yet the valuation signals are split, with an intrinsic value estimate based on a Discounted Cash Flow (DCF) model pointing to meaningful upside while earnings based multiples suggest the shares screen as expensive. Over the past 5 years, HealthEquity has returned 61.0%, which puts more focus on whether the current price still offers a margin of safety. Expectations around HealthEquity's ability to convert its revenue base...

Earlier this month, Replimune Group announced that the FDA granted accelerated approval for TUDRIQEV (vusolimogene oderparepvec-wtpg) in combination with nivolumab to treat adults with unresectable advanced cutaneous melanoma that has progressed after anti-PD-1 antibody-based therapy. This decision brings the first approved oncolytic HSV-1 viral therapy for this difficult-to-treat melanoma setting into clinical practice, anchored on objective response rate and duration of response from the...